Burns Charest has received the award for Outstanding Achievement in Antitrust Litigation for Private Law Practice from the American Antitrust Institute. The honor recognizes the work of the team of Warren Burns, Spencer Cox, and Amanda Klevorn in prevailing in a complex RICO and antirust action alleging a series of anti-competitive practices by the makers of the EpiPen auto-injector device, ultimately reaching a $609 million class-wide settlement. In presenting the award, which was shared with five other firms, the AAI noted the case was “exceptionally important for not only the antitrust bar but for American consumers as a whole, providing an enormous benefit to patients.”

In addition to the firm award, Spencer Cox was honored by the AAI with the award for Outstanding Antitrust Litigation Achievement by a Young Lawyer for his work on the EpiPen matter.